Target’s decision to start selling hemp-derived THC beverages marks a major milestone for the cannabis industry and a reality check for brands hoping to follow. Selling into mass retail is not just about scaling production or packaging appeal. It requires proving that your product meets the [...]
The private medical cannabis clinic Alternaleaf says it is responding to the “medical misogyny” crisis that has left 630,000 women waiting for NHS gynaecology care, with endometriosis taking an average eight years to diagnose. This story first appeared on leafie, view here Author: Liam O'Dowd
Medical cannabis patients will host a major educational event in the UK next month, aiming to bridge the gap between patients and healthcare professionals through evidence, empathy and lived experience. The international patient-led organisation We, The Patients, will bring its educational series to London next month [...]
Research involving over 130,000 people reveals genetic variants associated with brain signalling and impulsivity may also influence cannabis use patterns. This story first appeared on leafie, view here Author: Kevin Dinneen
In cannabis, it sometimes feels like every financial conversation ends the same way: “If not for 280E, we’d be thriving.” That line gets repeated in boardrooms and investor decks across the country, and for good reason. Section 280E has choked margins, slowed growth, and kept great [...]
Global cannabis trade is well underway as legalized countries move forward to establish a supply chain infrastructure in a newly formed and rapidly evolving industry. At the forefront of transportation logistics is Cannabilog, an Israeli company led by pharmaceutical industry veteran Yoram Eshel. In an interview, [...]
The soil cannabis is grown in directly affects the levels of cannabinoids such as CBD, CBG and THC, a first-of-its-kind, federally funded study has found. This story first appeared on leafie, view here Author: Kevin Dinneen
Experts say real-world evidence could offer crucial insights into how these medicines work in practice, and help widen access for patients. For the last 50 years, randomised controlled trials (RCTs) have been considered the ‘gold standard’ research methodology for measuring the safety and efficacy of new [...]
New research suggests the popular opioid painkiller offers minimal relief for chronic pain whilst significantly increasing the risk of heart problems and other serious side effects, highlighting the need for alternative, safer treatments, such as cannabis. This story first appeared on leafie, view here Author: Liam [...]
In a historic move, Spain’s Council of Ministers has approved a long-awaited Royal Decree regulating the medicinal use of cannabis preparations in hospital settings. Following years of advocacy on behalf of patients and campaigners, the decision marks a decisive step toward the integration of medical cannabis [...]
As our bodies age, the mechanisms that keep our systems humming, such as immune regulation, metabolism, and neural repair, gradually erode. That loss of homeostasis is the culprit behind many age-related disorders, from cognitive decline to metabolic dysfunction. Scientists are beginning to explore whether cannabis or [...]
A Royal Decree has authorised the limited use of medical cannabis in hospitals, allowing specialists to issue prescriptions for oils when treating conditions where conventional treatments have proved ineffective. This story first appeared on leafie, view here Author: Liam O'Dowd
Germany’s booming cannabis market, which Prohibition Partners now estimates to be worth around €670m, is entering uncertain and potentially treacherous territory. As the landmark CanG Act approaches its second year, it has become a highly charged and increasingly divisive issue politically, culturally, and medically. With the [...]
The study revealed that cannabis use initiated in later life may offer therapeutic benefits, while lifetime use beginning early could harm cognitive function in older adults. This story first appeared on leafie, view here Author: Kevin Dinneen
Q&A with Brendan McGee, Founder, Silver Therapeutics Tell us about your product(s). What do you make or sell, and what should people know about it? At Silver Therapeutics, we’re driven to curate experiences that meet people where they are. From flower to prerolls to vapes, we [...]
Alibi Cannabis website. Q&A Tell us about your product(s). What do you make or sell, and what should people know about it? Our roots are in cultivation, so everything starts with high-quality flowers. In Oregon, our flower has won multiple awards, and we bring that focus [...]
Website: rosareta.com Tell us about your product(s). What do you make or sell, and what should people know about it? Rosa Reta crafts solventless cannabis Live Rosin vapes (All-In-One), Bubble Hash Infused prerolls, and Rosin infused gummies. We focus on clean processing, full-spectrum flavor, and consistent quality [...]
The cannabis industry’s fragmented foundation is creating a host of problems tied to the lack of federal legalization. Many experts believe that without a national medical cannabis framework, the future of cannabis as a medicine in America could leave patients unprotected, research underfunded, and the industry [...]
At PatientsCann UK, we represent the voices of patients who rely on safe, effective, and regulated access to medical cannabis. Since its legalisation in 2018, many people have continued to face unnecessary barriers to treatment, from stigma and misinformation to the limited availability of NHS prescriptions. For thousands of patients, private prescriptions remain the only viable route to accessing the medicine they need. That’s why the Department of Health and Social Care’s “Private (non-NHS) Prescribing: Call for Evidence” is such an important opportunity. This review could influence how private prescribing works in the UK, including how cannabis-based medicines are accessed, regulated, and supported by clinicians. Why This Matters The call for evidence invites responses from across the healthcare system, including clinicians, prescribers, pharmacists, healthcare organisations, and patient groups. While the questions are primarily aimed at professionals, it is crucial that patients and carers also share their experiences. By contributing evidence and lived experience, we can help policymakers understand: How private prescribing supports patients who are unable to access NHS treatment. The challenges of affordability, continuity of care, and stigma in private medical cannabis access. The need for greater clinical education and confidence around prescribing cannabis-based medicines. The importance of protecting safe, regulated, and equitable access for all patients. Our Position PatientsCann UK believes that this review must:Protect the right of patients to access regulated medical cannabis safely and affordably.Promote fairness and consistency between NHS and private prescribing pathways.Address stigma and empower clinicians to prescribe based on evidence, not fear.Encourage more research, education, and evidence-based practice across the medical field. This consultation provides a rare chance to shape how the UK approaches private prescribing, and to ensure medical cannabis patients are not overlooked. How to Take Part Your experience is evidence — share it.The Private (non-NHS) Prescribing: Call for Evidence is now open to submissions from individuals and organisations with knowledge or experience of private prescribing. Visit: Private (non-NHS) Prescribing: Call for Evidence – GOV.UKDeadline: 11:59 pm, 4 November 2025 You do not need to answer every question, but you must select Submit at the end for your response to count. How Patients Can Encourage Healthcare Professionals You can play an important role in raising awareness of this consultation within your own care networks. Here are a few ways to help: Start the conversation. Mention the review to your prescribing clinician, pharmacist, or nurse and let them know the deadline. Many professionals may not yet be aware of it. Share the link. Send your clinic, GP practice, or specialist the official GOV.UK consultation page and encourage them to share it with colleagues. Speak to both sides. Whether your care is through a private medical cannabis clinic or the NHS, professionals across both systems can contribute valuable insight on access, patient safety, and clinical challenges. Explain why it matters. Let them know that evidence from healthcare professionals — especially those working with medical cannabis — can directly shape how government policy supports safer and fairer access for patients. Spread awareness. Share our post and tag your clinic, pharmacy, or medical organisation on social media to encourage wider participation. Your voice can help ensure that both patients and healthcare professionals are represented in this important review. Important Note This consultation is separate from the ACMD call for evidence on cannabis-based medicinal products, which focuses on clinical data and scheduling. Both reviews are crucial, and we encourage responses to each. Together, we can ensure that clinicians, patients, and organisations play a leading role in shaping an equitable and evidence-based future for medical cannabis access in the UK. 💚
The post Help Shape The Future of Medical Cannabis first appeared on PatientsCann UK.
A comprehensive survey of 1,450 chronic pain patients found that 86% reported moderate to significant pain improvement after using medical cannabis, with over a third able to eliminate other prescription medications entirely. This story first appeared on leafie, view here Author: Liam O'Dowd
The cannabis industry is a fertile ground for aspiring entrepreneurs, holding the promise of a modern-day gold rush. Yet beneath the surface of opportunity lies a minefield of obstacles. Success requires navigating a steep learning curve, managing high operational costs, and mastering a complex supply chain [...]
Dr Sue Clenton, Medical Director of Releaf cannabis clinic explains what it takes to go from a few hundred to thousands of patients, without compromising on the quality of care. When people talk about growth in healthcare, the conversation often centres on numbers – the number [...]
New guidelines around THC levels, dosages, and eligibility, aim to bring more clarity and consistency to the practice of prescribing cannabis-based medicines in the UK. Almost seven years since medical cannabis was legalised in the UK, around 180 specialist consultants are now actively prescribing. But almost [...]
The Advisory Council on the Misuse of Drugs (ACMD) is reviewing cannabis-based products for medicinal use (CBPMs).
The post PatientsCann UK Statement on the ACMD Review of Medical Cannabis first appeared on PatientsCann UK.
Research commissioned by the German government has found that teenage cannabis consumption has fallen since Germany's Cannabis Act (CanG) became law in April 2024. This story first appeared on leafie, view here Author: Liam O'Dowd
Words by Lawrence Purkiss and Sarah Sinclair Portugal hosted its seventh international conference on medical cannabis (PTMC) in central Lisbon last week, amid a growing feeling that the country – a once-thriving hub for European cannabis exports – is at an inflection point. Discussion among speakers [...]
A full-spectrum cannabis extract has shown significant pain reduction in patients with chronic lower back pain, offering hope for a new treatment option in a field desperate for alternatives to opioids. This story first appeared on leafie, view here Author: Liam O'Dowd
Beyond its wellness benefits, cannabis carries a rich and diverse cultural legacy that spans the globe. In a technical paper submitted to Mondiacult 2025, the Cannabis Embassy calls for global recognition of cannabis cultures as an integral part of humanity’s cultural diversity, and as essential to [...]
On April 1, 2024, Germany launched Pillar 1 of its adult-use legalization framework, building on its established medical cannabis program that has been in place since 2017. Since then, the number of medical patients has surged, as prescriptions remain the only fully legal access point for [...]
The next evolution of marketing in the cannabis industry has arrived. Global Compliance Application Corp. (GCAC), a publicly traded Canadian company specializing in blockchain technology, has launched Citizen Green, a connected TV (CTV) channel designed to educate viewers on various aspects of the cannabis industry. The [...]
The legal cannabis market generated nearly C$29 billion in total output whilst supporting over 227,000 jobs across the country, according to a Canadian Government report. This story first appeared on leafie, view here Author: Kevin Dinneen
By Rupa Shah, Head of Compliance at Releaf The conversation around workers’ rights and medical cannabis is still at a very early stage in the UK. Despite the fact that thousands of patients now access cannabis-based medicines legally through prescription, the framework remains poorly understood by [...]
Over the course of three years, across 13 regulated U.S. markets, BayMedica, a company specializing in the production and distribution of rare cannabinoids, identified three key insights into market demand for these compounds. First, products featuring THCV posted a 23.7% higher average retail margin than comparable [...]
Mental health advocate and one half of music duo Rizzle Kicks, Jordan Stephens, is collaborating with medical cannabis clinic, Alternaleaf, to shed light on the role of alternative treatments in supporting mental wellbeing. Stephens, who is currently touring with Rizzle Kicks as part of their comeback [...]
Jordan Stephens partners with UK medical cannabis clinic Alternaleaf to highlight alternative treatments for men's mental health through a spoken word performance. This story first appeared on leafie, view here Author: Liam O'Dowd
The research found that the number of visits to A&E related to suicide remained stable after legalisation, despite an increase in cannabis use. This story first appeared on leafie, view here Author: Kevin Dinneen
The UK’s medical cannabis industry is now the second largest in Europe, second only to Germany, thanks to consistent and sustained growth over the last seven years. While this has seen thousands of new patients gain access to medical cannabis, it still represents just a fraction [...]
A Yorkshire man, who supplied cannabis products to thousands of people with chronic illnesses, has been jailed for four years after his original suspended sentence was overturned. Joel Cunningham, 40, from Leeds, was convicted of seven offences, including possession with intent to supply magic mushrooms and [...]
Red Light Holland (CSE: TRIP) has established its foundation in the Netherlands, where psilocybin truffles, the underground sclerotia of psilocybin mushrooms, are legally permitted for cultivation and sale. The above-ground mushroom is prohibited, but the truffle is treated differently under Dutch law, despite delivering the same [...]
MJBizCon, the largest and one of the most influential gatherings in the cannabis industry, is adding a new element to its lineup: a cannabis competition. This year marks the debut of the MJBowl awards on December 4th in Las Vegas, produced in partnership with Budist, the [...]
In an industry defined by local operators struggling to stay afloat and confined within their borders, Michael Sassano, founder and CEO of Somai Pharmaceuticals, has created a blueprint for scaling cannabis worldwide with pharmaceutical discipline and regulatory agility. With headquarters in Lisbon and operations in [...]
Whether it’s a single retail license, a multi-site operation, or a vertically integrated enterprise, deals in Arizona are fetching top-tier premiums – often exceeding price points in larger, more mature markets like California. So, what’s driving these sky-high valuations? More importantly, how can industry players take [...]
Researchers conducted two studies into the driving skills of frequent cannabis users, finding no signs of impairment after 48 hours of abstinence and no difference in driving performance against a control group of non-users. This story first appeared on leafie, view here Author: Kevin Dinneen
Cannabis Health has partnered with leading experts at the Medical Cannabis Clinicians Society (MCCS) to bring its first educational event for healthcare professionals to the UK later this year. The Cannabis Health Symposium, taking place at Conway Hall in London on 25 November, 2025, will welcome [...]
A man who supplied cannabis products to people suffering from illness has been sentenced to four years in prison after the Court of Appeal overturned his original suspended term. This story first appeared on leafie, view here Author: Liam O'Dowd
New analysis has found that NHS access to medical cannabis could boost the UK’s economy by £13.3 billion over the next decade by returning thousands back to work. Widening NHS access to medical cannabis could add £4.5 billion to the economy over five years, and £13.3 [...]
Switching from smoking to dry-herb vaping offers a safer way to consume while also preserving the delicate terpene and cannabinoid profiles that contribute to the entourage effect. Unlike combustion, which produces tar, carbon monoxide, and other toxic byproducts, vaporization heats cannabis at controlled temperatures to release [...]
A major new study, analysing data from over four million adults in the US and Europe, has linked cannabis use to an almost quadrupling in the risk of developing type 2 diabetes. Cannabis use is increasing globally with an estimated 219 million users (4.3% of the [...]
The excitement and interest around New Jersey are impossible to ignore because of its potential to be one of the most lucrative cannabis markets in the country. Since legalization, operators have been racing to open doors, capture consumers, and keep pace with evolving regulations, as they [...]
The age of cannabis receiverships is here. If you’re a creditor, operator, landlord, or investor in a troubled cannabis business, you have a choice: watch value evaporate, or step up and run a disciplined, court-supervised sale that maximizes recoveries and preserves the company as a going [...]
Copyright © 2020 – 2026 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
